Add time:09/01/2019         Source:sciencedirect.com

(−)-6-[2-[4-(3-Fluorophenyl)-4-hydroxy-1-piperidinyl]-1-hydroxyethyl]-3,4-dihydro-2(1H)-quinolinone was identified as an orally active NR2B-subunit selective N-methyl-d-aspartate (NMDA) receptor antagonist. It has very high selectivity for NR2B subunits containing NMDA receptors versus the HERG-channel inhibition (therapeutic index = 4200 vs NR2B binding IC50). This compound has improved pharmacokinetic properties compared to the prototype CP-101,606.

We also recommend Trading Suppliers and Manufacturers of 4-Methyl-1-(1-piperidinyl)-1-penten-3-one (cas 13606-83-2). Pls Click Website Link as below: cas 13606-83-2 suppliers